4//SEC Filing
Pine Michael Craig 4
Accession 0001562180-23-008172
CIK 0001314102other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 5:20 PM ET
Size
8.9 KB
Accession
0001562180-23-008172
Insider Transaction Report
Form 4
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-04$12.62/sh+45,000$567,900→ 50,343 total - Sale
Common Stock
2023-12-04$22.00/sh−45,000$990,000→ 5,343 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-04−45,000→ 55,000 totalExercise: $12.62Exp: 2032-01-10→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Includes 2,159 shares acquired on January 31, 2023 and 2,184 shares acquired on July 31,2023 pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
- [F2]The option to purchase will vest and become exercisable as follows: 25% at January 10th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001904458
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 5:20 PM ET
- Size
- 8.9 KB